Но мне уже не смешно и даже не злорадно. Как-то не по себе, особенно если задуматься о расстановке сил на поле боя. И есть в этой истории несколько важных моментов, которые я прокомментирую после того, как все желающие ознакомятся с первоисточниками. 2004 was a triumphant year for Homme Hellinga, James B. Duke professor of biochemistry. He had just received a $2.5 million Director's Pioneer award from the National Institutes of Health, won a $10,000 Feynman Prize and discovered a way to engineer a powerful enzyme from a simple protein. The following year, he secured a titled professorship at the University. Hellinga's accomplishments shone with promise-both Duke and the field were excited for the future.
But three years later, those sentiments dimmed. John Richard, professor of chemistry at the State University of New York at Buffalo, had collaborated with Hellinga on his research. But in 2007, while Richard and his own team followed Hellinga's notes, they discovered that his designed enzyme-whose details were published in Science magazine [Science_04v304_1967_NovoTIM.rar] and the Journal of Molecular Biology - did not perform as Hellinga alleged it did, according to a 2008 article in Nature magazine [Nature_08v453_275_Hellinga.rar]. Suspicions began to rise about the decorated scientist's integrity.
Код: Выделить всё
http://dukechronicle.com/article/questions-linger-about-hellinga-case
http://dukechronicle.com/article/after-hellinga-review-closes-admins-quiet
http://dukechronicle.com/article/hellinga-case-demands-resolution
http://www.facebook.com/note.php?note_id=183635992891
http://writedit.wordpress.com/2009/10/13/hellinga-controversy-expands/#comments
- объяснить суть этой истории на русском. 
